DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
McInnes IB, Mease PJ, Kirkham B. et al.
Secukinumab, a human anti-interleukin-17 A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet 2015;
386: 1137-1146
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.